BiologicalDrug

VRC07-523LS clinical trials

Also written VRC07-523LS.

studies test it: 22
open now: 4
in phase 3: 0
first study started: 2015

Keep track of what changes. Save the VRC07-523LS studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

22 studies that test it; most in 2018 (3)

Studies that test VRC07-523LS, by start year
Year	Studies
2015	2
2017	2
2018	3
2019	3
2020	1
2021	1
2022	2
2023	2
2024	1
2025	2
2026	3

By phase

A phase 1/2 study counts in both.

Phase 1: 18
Phase 2: 8

What it is tested for

Each study’s main condition, where its own words name it.

HIV Infections: 8
Acquired Immunodeficiency Syndrome: 2
Infections: 2

Who runs them

Industry 2 · Other 20

National Institute of Allergy and Infectious Diseases (NIAID) (15) · TaiMed Biologics Inc. (1) · David Ho (1) · Boris Juelg, MD PhD (1) · Gilead Sciences (1) · International AIDS Vaccine Initiative (1) · University of North Carolina, Chapel Hill (1) · Henry M. Jackson Foundation for the Advancement of Military Medicine (1)

Often tested with

Tested in the same studies.

PGDM1400LS (5) · PGT121.414.LS (3) · Ad26.Mos4.HIV (2) · PGT-121 (2) · VRC-01LS (2) · VRC-01 (2) · TMB-365 (1) · Ibalizumab (1)

Studies

Open first, then newest update. How each study uses VRC07-523LS is read from its arms, and is right about nine times in ten.

Testing it · 22

See all 22 studies that test VRC07-523LS →

Given in every arm · 4 — VRC07-523LS is usual care beside what is tested